Soleil Boughton - 27 Feb 2026 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton
Issuer symbol
HIMS
Transactions as of
27 Feb 2026
Net transactions value
-$70,742
Form type
4
Filing time
02 Mar 2026, 16:18:08 UTC
Previous filing
25 Feb 2026
Next filing
13 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boughton Soleil Chief Legal Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton 02 Mar 2026 0001837817

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale $70,742 -4,651 -1% $15.21 440,972 27 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.